Market revenue in 2023 | USD 2.0 million |
Market revenue in 2030 | USD 4.8 million |
Growth rate | 13.2% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Orthopedic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the Brazil 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
The market has been exhibiting substantial growth, driven by a confluence of factors that include government support, active participation of academic institutes, and the presence of key industry players. Brazil's government played a pivotal role in fueling the growth of 3D printing technology by investing in R&D initiatives and creating a favorable regulatory environment.
This support incentivized innovation and provided a foundation for the expansion of 3D printed drugs. Brazil's 3D printed drugs market is expected to grow owing to the country's increasing focus on healthcare innovation and accessibility.
For instance, in February 2022, researchers from the Federal University of São Paulo (UNIFESP) in Brazil developed a method to print brain cells via 3D printing. Moreover, the cells are expected to survive for at least 14 days post-printing.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into Brazil 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account